Macy's, Inc. (0JXD.L)
USD 15.94
(-5.74%)
USD 15.94
(-5.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.3 Billion | 1.61 Billion | 2.71 Billion | 649 Million | 1.6 Billion | 1.73 Billion |
| Net Income | 105 Million | 1.17 Billion | 1.43 Billion | -3.94 Billion | 564 Million | 1.09 Billion |
| Depreciation & Amortization | 897 Million | 857 Million | 874 Million | 959 Million | 981 Million | 962 Million |
| Deferred income taxes | -244 Million | -38 Million | 19 Million | -327 Million | -6 Million | -389 Million |
| Stock-based compensation | 47 Million | 54 Million | 55 Million | 31 Million | 38 Million | 63 Million |
| Change in working capital | -614 Million | -454 Million | 195 Million | 262 Million | -254 Million | -208 Million |
| Other non-cash items | 1.11 Billion | 19 Million | 139 Million | 3.66 Billion | 285 Million | 209 Million |
| Investing Cash Flow | -913 Million | -1.16 Billion | -370 Million | -325 Million | -1 Billion | -456 Million |
| Investments in PPE | -993 Million | -1.29 Billion | -597 Million | -466 Million | -1.15 Billion | -932 Million |
| Acquisitions | 86 Million | 137 Million | 164 Million | 113 Million | 185 Million | 481 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6 Million | -11 Million | 63 Million | 28 Million | -30 Million | 476 Million |
| Financing Cash Flow | -220 Million | -1.29 Billion | -2.38 Billion | 699 Million | -1.12 Billion | -1.54 Billion |
| Debt repayment | -2 Million | -3.1 Billion | -2.58 Billion | -2.04 Billion | -597 Million | -1.14 Billion |
| Dividends payments | -181 Million | -173 Million | -90 Million | -117 Million | -466 Million | -463 Million |
| Common Stock Repurchased | -38 Million | -601 Million | -500 Million | -1 Million | -1 Million | - |
| Common Stock Issuance | - | - | 7 Million | 2.78 Billion | 6 Million | 45 Million |
| Other Financing Activities | 1 Million | 2.57 Billion | 791 Million | 86 Million | -65 Million | 23 Million |
| Accounts receivables | 7 Million | -3 Million | -21 Million | 183 Million | 80 Million | -40 Million |
| Accounts payables | -460 Million | -303 Million | 463 Million | -522 Million | -217 Million | 99 Million |
| Inventory | -99 Million | 116 Million | -610 Million | 1.4 Billion | 75 Million | -87 Million |
| Other working capital | -62 Million | -264 Million | 363 Million | -805 Million | -192 Million | -180 Million |
| Cash at beginning of period | 862 Million | 1.71 Billion | 1.75 Billion | 731 Million | 1.24 Billion | 1.51 Billion |
| Cash at end of period | 1.03 Billion | 865 Million | 1.71 Billion | 1.75 Billion | 731 Million | 1.24 Billion |
| Capital Expenditure | -993 Million | -1.29 Billion | -597 Million | -466 Million | -1.15 Billion | -932 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 172 Million | -850 Million | -39 Million | 1.02 Billion | -517 Million | -265 Million |
| Free Cash Flow | 312 Million | 320 Million | 2.11 Billion | 183 Million | 451 Million | 803 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 150 Million | 62 Million | 105 Million | -71 Million | 42 Million | -22 Million |
| Depreciation & Amortization | 213 Million | 216 Million | 897 Million | 232 Million | 232 Million | 215 Million |
| Deferred income taxes | -25 Million | -10 Million | -244 Million | -201 Million | 3 Million | -14 Million |
| Stock-based compensation | 15 Million | 13 Million | 47 Million | 2 Million | 15 Million | 16 Million |
| Change in working capital | -311 Million | -174 Million | -614 Million | 212 Million | -426 Million | -154 Million |
| Other non-cash items | 618 Million | 593 Million | 1.11 Billion | 973 Million | 21 Million | 125 Million |
| Investing Cash Flow | -156 Million | -217 Million | -913 Million | -197 Million | -185 Million | -261 Million |
| Investments in PPE | -203 Million | -229 Million | -993 Million | -244 Million | -185 Million | -268 Million |
| Acquisitions | 47 Million | 4 Million | 86 Million | 50 Million | 4 Million | 7 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -39 Million | 8 Million | -6 Million | -3 Million | -4 Million | -86 Million |
| Financing Cash Flow | -82 Million | -70 Million | -220 Million | -280 Million | 224 Million | -70 Million |
| Debt repayment | -34 Million | -22 Million | -2 Million | -160 Million | -159 Million | -22 Million |
| Dividends payments | -48 Million | -48 Million | -181 Million | -46 Million | -45 Million | -45 Million |
| Common Stock Repurchased | - | - | -38 Million | - | - | -3 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34 Million | -21 Million | 1 Million | -74 Million | 110 Million | -22 Million |
| Accounts receivables | -10 Million | 35 Million | 7 Million | -75 Million | 25 Million | 10 Million |
| Accounts payables | -513 Million | 112 Million | -460 Million | -1.48 Billion | 1.5 Billion | -430 Million |
| Inventory | 312 Million | -273 Million | -99 Million | 1.65 Billion | -1.89 Billion | 478 Million |
| Other working capital | -100 Million | -48 Million | -62 Million | 118 Million | -56 Million | -212 Million |
| Cash at beginning of period | 876 Million | 1.03 Billion | 862 Million | 364 Million | 441 Million | 606 Million |
| Cash at end of period | 646 Million | 876 Million | 1.03 Billion | 1.03 Billion | 367 Million | 441 Million |
| Capital Expenditure | -203 Million | -229 Million | -993 Million | -244 Million | -185 Million | -268 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -230 Million | -158 Million | 172 Million | 670 Million | -74 Million | -165 Million |
| Free Cash Flow | -195 Million | -100 Million | 312 Million | 903 Million | -298 Million | -102 Million |
TASA3
BTS-R
357780
FGRRF
7585
TCMFF